Research Focus Area:
Treatment, Detection, Diagnosis/ Prognosis
Type of Research:
Research Interest Statement:
Research interests include investigating the efficacy of therapeutic vaccines in an adjuvant setting to reduce the risk of recurrence in head and neck cancers, the role of gut microbiome in head and neck cancers, and strategies to improve effectiveness of noval therapies for head and neck and lung cancers while minimizing adverse effects of such interventions.
“EA3191 A Phase II Randomized Trial of Adjuvant Therapy with Pembrolizumab after Resection of Recurrent/Second Primary Head and Neck Squamous Cell Carcinoma with High Risk Features ” (NCT04671667)
“A Phase I/II Clinical Trial of PepCan in Head and Neck Cancer Patients in Remission to Reduce Recurrence Regardless of HPV Status” (NCT03821272)
NIH/Nat. Cancer Institute – 2R01CA143130
“Understanding and Enhancing T-Cell Responses to High Risk Human Papillomaviruses-Renewal”
07/01/21 – 06/30/26
Crowley R, Atiq O, Hilden D, Cooney TG. Health Care for Our Nation's Veterans: A Policy Paper From the American College of Physicians. Annals of internal medicine. 2021. PMID: 34606323.
Crowley R, Atiq O, Hilden D. Financial Profit in Medicine: A Position Paper From the American College of Physicians. Annals of internal medicine. 2021. PMID: 34487452.
Atiq S, Atiq OO, Atiq ZO, [et al., including Atiq O]. A Case of Metastatic Pancreatic Adenocarcinoma in Complete Remission Using Chemotherapy and Immunotherapy. Cureus. 2021 13(2):e13133. PMID: 33728149. PMCID: PMC7935157.
Adkins D, Ley J, Atiq O, [et al.]. Nanoparticle albumin-bound paclitaxel with cetuximab and carboplatin as first-line therapy for recurrent or metastatic head and neck cancer: A single-arm, multicenter, phase 2 trial. Oral oncology. 2021 115:105173. PMID: 33548860.
Serchen J, Doherty R, Atiq O, Hilden D. A Comprehensive Policy Framework to Understand and Address Disparities and Discrimination in Health and Health Care: A Policy Paper From the American College of Physicians. Annals of internal medicine. 2021. PMID: 33428444.
Serchen J, Doherty R, Atiq O, Hilden D. Racism and Health in the United States: A Policy Statement From the American College of Physicians. Annals of internal medicine. 2020 173(7):556-557. PMID: 32559145.
Atiq O, Atiq SO, Atiq ZO, [et al., including Atiq O]. Pembrolizumab-Induced Cold Agglutinin Disease. The American journal of case reports. 2020 21:e924283. PMID: 32887867. PMCID: PMC7491957.
Wongsurawat T, Nakagawa M, Atiq O, [et al.]. An assessment of Oxford Nanopore sequencing for human gut metagenome profiling: A pilot study of head and neck cancer patients. Journal of microbiological methods. 2019 166:105739. PMID: 31626891. PMCID: PMC6956648.
Atiq SO, Atiq OO, Atiq MO, [et al., including Atiq OT]. The Role of Immunotherapy and Radiation Therapy in Tumor Chemosensitivity in Advanced Head and Neck Cancer. The American journal of case reports. 2018 19:1241-1244. PMID: 30333474. PMCID: PMC6202879.
Dunn A, Broadfoot BG, Hunt J, [et al., including Atiq O]. Metastatic laryngeal large cell neuroendocrine carcinoma: A rare case of presentation and extreme tumor burden. Journal of cutaneous pathology. 2018 45(3):229-233. PMID: 29194700.
Papanikolaou X, Rosenthal A, Dhodapkar M, [et al., including Atiq O]. Flow cytometry defined cytoplasmic immunoglobulin index is a major prognostic factor for progression of asymptomatic monoclonal gammopathies to multiple myeloma (subset analysis of SWOG S0120). Blood cancer journal. 2016 6:e410. PMID: 27015287. PMCID: PMC4817101.